Ireland· IE-PA-EU/1/17/1212/001-006
MAVENCLAD 10 mg tablets
A selective immunosuppressants product containing cladribine, registered in Ireland by Merck Europe B.V.. The same ATC class is registered in 5 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Cladribine is registered in 5 of 19 countries.
Countries holding a registration under ATC L04AA (selective immunosuppressants), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 2 of them publish a price we can compare per daily dose
Cladribine · ATC L04AA
5 / 19 countries
- Denmark
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Cladribine
- Manufacturer
- Merck Europe B.V.
- Country
- Ireland (IE)
- ATC code
- L04AA
- ATC class
- Selective immunosuppressants
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/17/1212/001-006
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cladribine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMAVENCLADMerck Europe B.V., Amsterdam
- United StatesCladribineSandoz Inc.
- FinlandMAVENCLADMerck Europe B.V.
- SwitzerlandMavenclad 10 mg, TablettenMerck (Schweiz) AG
- NorwayMavencladMerck Europe B.V.
- NetherlandsMavenclad 10 mg tablettenMerck Europe B.V.
- PolandMavencladMerck Europe B.V.
- SwedenMAVENCLAD 10 mg TablettMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Leuject
- Belgium · Leustatin
- Bulgaria · Леуджект
- Czechia · Leuject
- Germany · Leustatin
- Spain · Leustatin
- Finland · Leuject
- France · Leustatine
- United Kingdom (Northern Ireland) · Cladribine Zentiva, Leustat
- Greece · Leustatin
- Croatia · Leuject
- Hungary · Leuject
- Iceland · Mavenclad
- Italy · Leustatin
- Liechtenstein · Mavenclad
- Luxembourg · Leustatin
- Netherlands · Leustatin
- Norway · Leuject, Mavenclad
- Poland · Biodribin, Leuject
- Portugal · Cladribina Generis, Leustatin
- Romania · Leuject
- Sweden · Leuject
- Slovenia · Leuject
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9af1cff8-b04a-48bb-8b56-c8042c09a0b5 GET /v1/drugs/9af1cff8-b04a-48bb-8b56-c8042c09a0b5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L04AA"
],
"strength": null,
"pa_number": "EU/1/17/1212/001-006",
"substances": [
"Cladribine"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "22/08/2017",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about cladribine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.